Interesting that the move to combo in the OASIS trial was dependent on achieving the RP2D based on various criteria including increased cytokines and decrease in tumour according to clinical trials.gov, ie that the naked CF33 was doing as hoped before moving to the combo. I wonder if that means the dose has reached 3e9 in the Vaxinia trial. I can’t find the dose escalation rate for oasis but I recall other posters had the numbers. Does anyone have that info? Cheers.
Ann: Phase 1 onCARlytics Trial Advances to Combination Arm, page-34
-
- There are more pages in this discussion • 114 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1921794 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1368288 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |